Dexmedetomidine Prolongs the Duration of Ropivacaine Corneal Anesthesia After Subconjunctival Injection in Healthy Horses. [PDF]
Lee S, Hector RC, Hess AM, Wotman KL.
europepmc +1 more source
Prophylactic Use of Lipid Emulsion Therapy After Inadvertent Administration of 0.5% Ropivacaine for a Bier Block: A Case Report. [PDF]
Luong A +7 more
europepmc +1 more source
Liposomal bupivacaine for popliteal sciatic and saphenous nerve blocks in patients undergoing foot and ankle surgery: a single-center, double-blind, randomized controlled trial. [PDF]
Wang J +5 more
europepmc +1 more source
Hydromorphone is Noninferior to Dexamethasone as an Adjuvant to Ropivacaine for Transversus Abdominis Plane Block After Laparoscopic Colorectal Cancer Surgery: A Randomized, Double-Blind Trial. [PDF]
Zhao L +6 more
europepmc +1 more source
Intercostal nerve blocks take the lead: rethinking regional analgesia for video-assisted thoracic surgery. [PDF]
Villa JF, Donahue H, Rajaram R, Cata JP.
europepmc +1 more source
Efficacy of transmuscular quadratus lumborum block on postoperative nausea and vomiting: A meta-analysis of randomized controlled trials. [PDF]
Liang X +4 more
europepmc +1 more source
Related searches:
Ropivacaine (Naropin, AstraZeneca) is a long-acting amide local anaesthetic released for clinical use in 1996. Similar to bupivacaine, ropivacaine is equally effective for s.c. infiltration, epidural and peripheral nerve block for surgery, obstetric and post-operative analgesia.
M D, Owen, L S, Dean
openaire +3 more sources
Long-acting local anaesthetics are primarily used in the practice of anaesthesia, particularly in regional anaesthesia and analgesia. Ropivacaine is a new long-acting local anaesthetic that has been the focus of interest because of its increased cardiovascular safety compared with bupivacaine.
R D, Wang, L A, Dangler, R A, Greengrass
openaire +2 more sources

